Here is at bit of information about Herb Brinkman. Dr Thurn is putting together a really impressive team.
Definitely a heavy weight in his field of expertise and would not be joining PAA if he did not think Monepantel was the real deal IMO.
An experienced CMC Development professional with expertise in Active Pharmaceutical Ingredient development and manufacturing. Also experienced in Finished Drug Product manufacturing. Several years experience focusing on CMC Regulatory Strategy definition in alignment with company's IND, NDA, ANDA, and EMA filing goals. Timely execution of development programs meeting preclinical, formulation and CTM supply requirements. Author and reviewer of CMC submissions. Comprehensive knowledge of ICH Q series guidelines. Expertise includes GMP systems as applied to API manufacture and address of regulatory issues associated with CMC changes.
An extract from here https://www.linkedin.com/in/herb-brinkman-8103bb2/
Here is at bit of information about Herb Brinkman. Dr Thurn is...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $94.89M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 19.0¢ | $58.40K | 305.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 115000 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 86074 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |